Cargando…
Hepatotoxicity Secondary to Levofloxacin Use
Levofloxacin is a broad-spectrum antibiotic that is used in the treatment of many infections. A rare adverse drug reaction following the use of levofloxacin is drug-induced liver injury. The exact mechanism behind fluoroquinolone-induced liver injury is unknown, but many severe, sometimes fatal hepa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317250/ https://www.ncbi.nlm.nih.gov/pubmed/34336465 http://dx.doi.org/10.7759/cureus.15973 |
_version_ | 1783730035049365504 |
---|---|
author | Panahi, Ladan Surani, Salim Surani Udeani, George Patel, Niraj P Sellers, Jacob |
author_facet | Panahi, Ladan Surani, Salim Surani Udeani, George Patel, Niraj P Sellers, Jacob |
author_sort | Panahi, Ladan |
collection | PubMed |
description | Levofloxacin is a broad-spectrum antibiotic that is used in the treatment of many infections. A rare adverse drug reaction following the use of levofloxacin is drug-induced liver injury. The exact mechanism behind fluoroquinolone-induced liver injury is unknown, but many severe, sometimes fatal hepatotoxicity cases are reported. Current recommendations advise clinicians to discontinue levofloxacin immediately if the patient develops signs and symptoms of hepatitis. This case report presents a 79-year-old male who was prescribed levofloxacin 500 mg by mouth daily for seven days. The patient had a past medical history of dementia, seizures, cerebral vascular accident, pulmonary fibrosis, and chronic kidney disease. Upon admission, the patient began to show signs and symptoms of liver injury. We hereby present a case report and a review of significant literature on levofloxacin-induced liver injury. |
format | Online Article Text |
id | pubmed-8317250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-83172502021-07-31 Hepatotoxicity Secondary to Levofloxacin Use Panahi, Ladan Surani, Salim Surani Udeani, George Patel, Niraj P Sellers, Jacob Cureus Internal Medicine Levofloxacin is a broad-spectrum antibiotic that is used in the treatment of many infections. A rare adverse drug reaction following the use of levofloxacin is drug-induced liver injury. The exact mechanism behind fluoroquinolone-induced liver injury is unknown, but many severe, sometimes fatal hepatotoxicity cases are reported. Current recommendations advise clinicians to discontinue levofloxacin immediately if the patient develops signs and symptoms of hepatitis. This case report presents a 79-year-old male who was prescribed levofloxacin 500 mg by mouth daily for seven days. The patient had a past medical history of dementia, seizures, cerebral vascular accident, pulmonary fibrosis, and chronic kidney disease. Upon admission, the patient began to show signs and symptoms of liver injury. We hereby present a case report and a review of significant literature on levofloxacin-induced liver injury. Cureus 2021-06-27 /pmc/articles/PMC8317250/ /pubmed/34336465 http://dx.doi.org/10.7759/cureus.15973 Text en Copyright © 2021, Panahi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Panahi, Ladan Surani, Salim Surani Udeani, George Patel, Niraj P Sellers, Jacob Hepatotoxicity Secondary to Levofloxacin Use |
title | Hepatotoxicity Secondary to Levofloxacin Use |
title_full | Hepatotoxicity Secondary to Levofloxacin Use |
title_fullStr | Hepatotoxicity Secondary to Levofloxacin Use |
title_full_unstemmed | Hepatotoxicity Secondary to Levofloxacin Use |
title_short | Hepatotoxicity Secondary to Levofloxacin Use |
title_sort | hepatotoxicity secondary to levofloxacin use |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317250/ https://www.ncbi.nlm.nih.gov/pubmed/34336465 http://dx.doi.org/10.7759/cureus.15973 |
work_keys_str_mv | AT panahiladan hepatotoxicitysecondarytolevofloxacinuse AT suranisalimsurani hepatotoxicitysecondarytolevofloxacinuse AT udeanigeorge hepatotoxicitysecondarytolevofloxacinuse AT patelnirajp hepatotoxicitysecondarytolevofloxacinuse AT sellersjacob hepatotoxicitysecondarytolevofloxacinuse |